Logo image of ALDAR.PA

DAMARTEX (ALDAR.PA) Stock Fundamental Analysis

EPA:ALDAR - Euronext Paris - Matif - FR0000185423 - Common Stock - Currency: EUR

4.08  0 (0%)

Fundamental Rating

2

ALDAR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 39 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of ALDAR have multiple concerns. ALDAR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALDAR has reported negative net income.
In the past year ALDAR had a positive cash flow from operations.
ALDAR had negative earnings in 4 of the past 5 years.
Of the past 5 years ALDAR 4 years had a positive operating cash flow.
ALDAR.PA Yearly Net Income VS EBIT VS OCF VS FCFALDAR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

ALDAR has a worse Return On Assets (-5.22%) than 92.31% of its industry peers.
The Return On Equity of ALDAR (-25.81%) is worse than 84.62% of its industry peers.
Industry RankSector Rank
ROA -5.22%
ROE -25.81%
ROIC N/A
ROA(3y)-5.09%
ROA(5y)-4.83%
ROE(3y)-23.54%
ROE(5y)-23.61%
ROIC(3y)N/A
ROIC(5y)N/A
ALDAR.PA Yearly ROA, ROE, ROICALDAR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

ALDAR has a Gross Margin (64.44%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALDAR has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ALDAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.32%
ALDAR.PA Yearly Profit, Operating, Gross MarginsALDAR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

ALDAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALDAR remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALDAR has more shares outstanding
ALDAR has a worse debt/assets ratio than last year.
ALDAR.PA Yearly Shares OutstandingALDAR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALDAR.PA Yearly Total Debt VS Total AssetsALDAR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.74, we must say that ALDAR is in the distress zone and has some risk of bankruptcy.
ALDAR's Altman-Z score of 0.74 is on the low side compared to the rest of the industry. ALDAR is outperformed by 84.62% of its industry peers.
ALDAR has a debt to FCF ratio of 5.62. This is a neutral value as ALDAR would need 5.62 years to pay back of all of its debts.
ALDAR has a Debt to FCF ratio (5.62) which is comparable to the rest of the industry.
ALDAR has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.59, ALDAR is not doing good in the industry: 79.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 5.62
Altman-Z 0.74
ROIC/WACCN/A
WACC5.33%
ALDAR.PA Yearly LT Debt VS Equity VS FCFALDAR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALDAR has a Current Ratio of 0.69. This is a bad value and indicates that ALDAR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.69, ALDAR is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
ALDAR has a Quick Ratio of 0.69. This is a bad value and indicates that ALDAR is not financially healthy enough and could expect problems in meeting its short term obligations.
ALDAR has a Quick ratio of 0.31. This is amonst the worse of the industry: ALDAR underperforms 87.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.31
ALDAR.PA Yearly Current Assets VS Current LiabilitesALDAR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.73% over the past year.
Looking at the last year, ALDAR shows a decrease in Revenue. The Revenue has decreased by -9.59% in the last year.
ALDAR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.97% yearly.
EPS 1Y (TTM)50.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.69%
Revenue 1Y (TTM)-9.59%
Revenue growth 3Y-11.53%
Revenue growth 5Y-5.97%
Sales Q2Q%-1.95%

3.2 Future

ALDAR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.09% yearly.
ALDAR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -11.92% yearly.
EPS Next Y101.03%
EPS Next 2Y50.11%
EPS Next 3Y32.09%
EPS Next 5YN/A
Revenue Next Year-1.79%
Revenue Next 2YN/A
Revenue Next 3Y-11.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALDAR.PA Yearly Revenue VS EstimatesALDAR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 200M 400M 600M
ALDAR.PA Yearly EPS VS EstimatesALDAR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

6

4. Valuation

4.1 Price/Earnings Ratio

ALDAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 5.35, the valuation of ALDAR can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALDAR is valued cheaper than 100.00% of the companies in the same industry.
ALDAR is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 5.35
ALDAR.PA Price Earnings VS Forward Price EarningsALDAR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALDAR.
Based on the Price/Free Cash Flow ratio, ALDAR is valued cheaply inside the industry as 97.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.34
EV/EBITDA 9.08
ALDAR.PA Per share dataALDAR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

ALDAR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALDAR's earnings are expected to grow with 32.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.11%
EPS Next 3Y32.09%

0

5. Dividend

5.1 Amount

No dividends for ALDAR!.
Industry RankSector Rank
Dividend Yield N/A

DAMARTEX

EPA:ALDAR (5/9/2025, 7:00:00 PM)

4.08

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)03-04 2025-03-04
Earnings (Next)07-17 2025-07-17/amc
Inst Owners4.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap47.33M
Analysts40
Price Target5.41 (32.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-63.84%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6%
PT rev (3m)6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-98.23%
EPS NY rev (3m)-98.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.35
P/S 0.09
P/FCF 1.34
P/OCF 1.07
P/B 0.53
P/tB N/A
EV/EBITDA 9.08
EPS(TTM)-2.02
EYN/A
EPS(NY)0.76
Fwd EY18.68%
FCF(TTM)3.05
FCFY74.87%
OCF(TTM)3.81
OCFY93.29%
SpS44.9
BVpS7.63
TBVpS-3.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.22%
ROE -25.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.44%
FCFM 6.8%
ROA(3y)-5.09%
ROA(5y)-4.83%
ROE(3y)-23.54%
ROE(5y)-23.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.32%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 5.62
Debt/EBITDA 8.32
Cap/Depr 25.25%
Cap/Sales 1.67%
Interest Coverage N/A
Cash Conversion 260.63%
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.31
Altman-Z 0.74
F-Score5
WACC5.33%
ROIC/WACCN/A
Cap/Depr(3y)44.16%
Cap/Depr(5y)37.16%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.69%
EPS Next Y101.03%
EPS Next 2Y50.11%
EPS Next 3Y32.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.59%
Revenue growth 3Y-11.53%
Revenue growth 5Y-5.97%
Sales Q2Q%-1.95%
Revenue Next Year-1.79%
Revenue Next 2YN/A
Revenue Next 3Y-11.92%
Revenue Next 5YN/A
EBIT growth 1Y18.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year110.52%
EBIT Next 3Y20.14%
EBIT Next 5YN/A
FCF growth 1Y176.3%
FCF growth 3Y-26.44%
FCF growth 5Y28.36%
OCF growth 1Y245.85%
OCF growth 3Y-21.27%
OCF growth 5Y5.37%